Amantanium bromide

CAS No. 58158-77-3

Amantanium bromide( Amantanil bromidum )

Catalog No. M24573 CAS No. 58158-77-3

Amantanium bromide is a quaternary ammonium compound used as an antiseptic/disinfectant for therapeutic function.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 432 In Stock
5MG 661 In Stock
10MG 895 In Stock
25MG 1321 In Stock
50MG 1739 In Stock
100MG 2353 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Amantanium bromide
  • Note
    Research use only, not for human use.
  • Brief Description
    Amantanium bromide is a quaternary ammonium compound used as an antiseptic/disinfectant for therapeutic function.
  • Description
    Amantanium bromide is a quaternary ammonium compound used as an antiseptic/disinfectant for therapeutic function.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Amantanil bromidum
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    58158-77-3
  • Formula Weight
    472.54
  • Molecular Formula
    C25H46BrNO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCCCCCCCCC[N+](C)(C)CCOC(C1(CC(C2)C3)CC3CC2C1)=O.[Br-]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Richard C. Allen. Chapter 32. To Market, To Market—1984[J]. Annual Reports in Medicinal Chemistry, 1985, 20:315-325.
molnova catalog
related products
  • DFHBI-1T

    DFHBI-1T is an RNA aptamer-activated fluorescent probe that transmits through cell membranes.DFHBI-1T can be used for dynamic localization imaging of RNA in living cells.

  • Glycolithocholic aci...

    Glycolithocholic acid is a glycine conjugate of lithocholic acid.

  • Flaviviruses-IN-3

    Flaviviruses-IN-3 (compound 87) is a potent inhibitor of flaviviruses, capable of reducing West Nile virus (WNV) protease activity by 54%.